Wick Capital Partners, LLC

Position in VKTX — Viking Therapeutics, Inc.

CIK 1904388 WAYNE, PA

Position in VKTX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$186,272

+$66,883 QoQ

Shares Held

4,775

+30.1% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

#300

of 432 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Wick Capital Partners, LLC holds $600,789 across 3 Biotechnology names. VKTX ranks #3 (31.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BMRN	Biomarin Pharmaceutical Inc	3,687	$210,970
2	EXEL	Exelixis, Inc.	3,741	$203,547
3	VKTX	Viking Therapeutics, Inc. This page	4,775	$186,272

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$186,272	4,775	+30.1%	Shares	Sole	2026-08-14
2026-03-31	$119,389	3,669	+11.8%	Shares	Sole	2026-05-15
2025-12-31	$115,460	3,282	—	Shares	Sole	2026-03-02
No filing history on record for this holder in this stock.